A powerful ultrasound can significantly reduce the number of American women who undergo surgery to tell if their breast lumps are cancerous or benign, government scientists said Monday.
The scientific panel unanimously urged the Food and Drug Administration to approve the High-Definition Imaging, or HDI, ultrasound as a test to help doctors decide which women need a biopsy and which can skip the surgery.
“This will help women in general who have suspicious lesions,” said Dr. David Hackney, a radiologist at the University of Pennsylvania Hospital.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe to the Coronavirus newsletter
Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.